1. ALLA AKTIER
  2. NYHETER
  3. PROSTALUND

ProstaLund

Nyheter ProstaLund Nyheter alla bolag

An eventful quarter with growth and agreements

MAR

1 April-30 June

  • Net sales reached SEK 3,5 (3,2) million
  • Loss after taxes SEK -3,7 (-2,8) million
  • Earnings per share were SEK -0,07 SEK (-0,07)
  • Cash and equivalents were 4,4 (2,8) million

Significant events during period

  • Agreement with Capio Specialistcenter. Order value SEK 2.4 million
  • Agreement with Urogyn Sweden. Order value SEK 1,2 million
  • The new platform, CoreTherm® Eagle, submitted for CE marking
  • Distribution agreement signed for the Israeli market

1 April-30 June

  • Net sales reached SEK 8,1 (8,5) million
  • Loss after taxes SEK -5,8 (-3,9) million
  • Earnings per share were SEK -0,11 SEK (-0,09)

Significant events after the end of the period

  • The Board decides on a rights issue, which can provide the company with up to SEK 18 million before issue costs
Key figures


(SEK MILLION)jan-jun
2022		jan-jun
2021		jan-jun
2020
Net sales8,18,56,1
Gross margin, %768766
Operating profit/loss-5,8-3,9-4,7
Cash flow from operating activities-9,5-3,2-4,2
Average number of employees775

“When I look at how the quarter developed with strong sales in the domestic market, submission for CE marking of the new platform and the great interest from the rest of Europe, I think it looks very exciting”

Johan Wennerholm
CEO, ProstaLund AB (publ)

*For complete report, please see attached PDF.


For further information, please contact:

Johan Wennerholm,  CEO
Tel. +46 (0) 730 429997
Email: johan.wennerholm@prostalund.com

About ProstaLund

ProstaLund AB is a Swedish medical technology company and a leading developer and manufacturer of innovative urological devices and treatments. The company’s lead product, CoreTherm, is a patented Thermotherapy treatment method for Benign Prostatic Hyperplasia (BPH) which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide. ProstaLund is listed on the Nasdaq First North Growth Market.

Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se

This information is information that ProstaLund AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-07-14 08:15 CEST.

Attachments

ProstaLund AB (punl) Interim Report Jan Jun 2022

Datum 2022-07-14, kl 08:15
Källa MFN
Bifogade filer
ProstaLund AB (punl) Interim Report Jan Jun 2022
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.